We are live on !
Find out more
Nordicus Partners
NORD
NORD
About: Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life sciences ecosystem, and drug discoveries and developments. Its current portfolio includes the preclinical biotechnology companies Orocidin A/S, Bio-Convert A/S, and NoviThera ApS. The Company is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs, starting with oral disorders. It operates in the segment focused on developing medicines supporting oral health.
News
Positive
Neutral
Negative
Sentiment
3-Months
Positive
0%
Neutral
0%
Negative
0%
We haven’t received any recent news articles for NORD
Price charts implemented using Lightweight Charts™